NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for opioid


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
AcelRx to Present at the Lazard 6th Annual Healthcare Conference
2009 NOV 23 ... analgesia (IV PCA) for the management of acute post-operative pain in patients requiring opioid analgesia during hospitalization; ARX-02, Sufentanil NanoTab Breakthrough Pain ...
Subject: Pharmaceuticals
Price: $3.00
*
Adolor Corporation Initiates Clinical Testing in Opioid Bowel Dysfunction Program
2009 NOV 23 ... announced the initiation of clinical testing of ADL7445, its proprietary, oral mu opioid receptor antagonist for the treatment of Opioid Bowel ...
Subject: Adolor Corporation
Price: $3.00
*
Data from INSERM advance knowledge in HIV/AIDS
2009 NOV 23 ... According to a study from Marseille, France, "The positive impact of opioid substitution treatment (OST) on opioid-dependent ...
Subject: HIV/AIDS
Price: $3.00
*
Findings in applied animal research reported from Shiraz University
2009 NOV 23 ... Journal of Applied Animal Research, "To study the effect of H-2 receptor blockers on opioid analgesics, 50 mice were divided into 5 equal groups including control group and those ...
Subject: Applied Animal Research
Price: $3.00
*
Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field
2009 NOV 23 ... Groundbreaking articles in current issues of Journal of Opioid Management, for the first time explore, in depth, the emergence of cannabinoid medicine, ...
Subject: Pain Management
Price: $3.00
*
New life sciences study findings have been published by F.L.O. Araujo and colleagues
2009 NOV 23 ... tests in mice. Moreover, the involvement of the nitric oxide pathway as well as the opioid system in the antinociceptive action of ripI in the formalin test was investigated." ...
Subject: Life Sciences
Price: $3.00
*
QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuoCR
2009 NOV 23 ... with Patheon to manufacture clinical supplies of QRxPharma's controlled release Dual-Opioid™ formulation (MoxDuo™CR). MoxDuo™CR is designed to provide 12 hours of ...
Subject: Biotech Business
Price: $3.00
*
Reports from College of Medicine add new data to research in clinical trial research
2009 NOV 23 ... want more pain medication?'' Patients in the physician-driven group received any IV opioid in the dose chosen by the ED attending physician, with any additional analgesia provided ...
Subject: Clinical Trial Research
Price: $3.00
*
Reports on bioscience findings from Nagasaki University provide new insights
2009 NOV 17 ... "The mechanisms underlying opioid tolerance are not fully understood, but appear to be comprised of two types of ...
Subject: Bioscience
Price: $3.00
*
Reports on opiate receptors findings from M.J. Glass and co-researchers provide new insights
2009 NOV 23 ... emotional processes that are critically involved in addictive behaviors. Glutamate and opioid systems in the CeA play significant roles in neural plasticity and addictive processes, ...
Subject: Opiate Receptors
Price: $3.00
*
Reports summarize opiate receptors study results from University of California
2009 NOV 23 ... in outcome value." "The present study assessed the role of the endogenous opioid system in goal-directed reward learning. In two experiments, rats were trained to lever ...
Subject: Opiate Receptors
Price: $3.00
*
Researchers' work from University of Barcelona focuses on inflammation
2009 NOV 23 ... Nonetheless, the role of nitric oxide in the local antinociceptive effects of delta-opioid receptor (DOR) agonists during chronic peripheral inflammation is not known," ...
Subject: Inflammation
Price: $3.00
*
Stress-induced changes in brain circuitry linked to cocaine relapse
2009 NOV 16 ... In explaining their study, the researchers said that the dynorphin/kappa opioid system, found in certain brain cells, can be activated either through repeated stress or ...
Subject: University of Washington
View Free
Daily News
Article
Studies from A.J. Kuszak et al have provided new data on opiate receptors
2009 NOV 16 ... "Despite extensive characterization of the mu-opioid receptor (MOR), the biochemical properties of the isolated receptor remain unclear. In ...
Subject: Opiate Receptors
Price: $3.00
*
Studies from M.Y. Smith and co-researchers yield new data on pharmaceuticals
2009 NOV 16 ... Avenue NW, Washington, DC 20037, USA. Keywords: United States, Analgesia, Opioid Analgesics, Pain Medicine, Pharmaceuticals, Therapy, Treatment. This ...
Subject: Pharmaceuticals
Price: $3.00
*
Studies from University of Washington further understanding of hormones
2009 NOV 16 ... Dyn and NKB genes but also the NKB receptor gene (NK3) and the Dyn receptor [the kappa opioid receptor (KOR)] gene. We also found that expression of the Dyn, NKB, KOR, and NK3 in the ...
Subject: Hormones
Price: $3.00
*
Sucampo Pharmaceuticals Reports Financial Results for the Third Quarter of 2009
2009 NOV 16 ... pivotal clinical trials of lubiprostone (24 mcg, twice daily) for the management of opioid-induced bowel dysfunction (OBD) in subjects with chronic, non-cancer pain. In one trial, ...
Subject: Sucampo Pharmaceuticals, Inc.
Price: $3.00
*
U.S. Department of Defense Awards $1.2 Million to Study the Use of Vigabatrin to Reduce the Addictive Liability of Opiates While Still Effectively Managing Pain
2009 NOV 23 ... opiates to effectively manage pain while reducing the potential for opiate addiction. Opioid abuse is one of the many substance addiction indications covered under Catalyst's ...
Subject: Addiction Medicine
Price: $3.00
*
URCH Publishing: Market for Addiction Treatment Medicines Set to Rise to $3.8bn, Forecasts New Report
2009 NOV 16 ... 2005. "The drug pipeline for the addiction disorders of alcohol, cocaine, opioid, methamphetamine, phencyclidine, cannabis, and tobacco dependence is now rich with a ...
Subject: URCH Publishing
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login